Always twisting what I say. First off, Sonnys been developing hip/knee implants for Sintx since 2006 which far predates him becoming CEO; this is important to establish as older contracts supersede newer contracts. Secondly, Sonnys team only works on Arthoplasty products meaning all others would be worked on by other third parties.
The purpose of doing this is to try to maintain a veil of secrecy. Can't count how many times ive heard Hanson or an analyst mention the goal of keeping competition from knowing whats its doing, for example.
Market Data 
Markets 
AI
